DOI record:
{
"DOI": "10.1016/j.rceng.2023.07.006",
"ISSN": [
"2254-8874"
],
"URL": "http://dx.doi.org/10.1016/j.rceng.2023.07.006",
"alternative-id": [
"S2254887423000929"
],
"assertion": [
{
"label": "This article is maintained by",
"name": "publisher",
"value": "Elsevier"
},
{
"label": "Article Title",
"name": "articletitle",
"value": "Impact of N-Acetylcysteine in the mortality of patients hospitalized with COVID-19: a retrospective cohort study"
},
{
"label": "Journal Title",
"name": "journaltitle",
"value": "Revista Clínica Española (English Edition)"
},
{
"label": "CrossRef DOI link to publisher maintained version",
"name": "articlelink",
"value": "https://doi.org/10.1016/j.rceng.2023.07.006"
},
{
"label": "CrossRef DOI link to the associated document",
"name": "associatedlink",
"value": "https://doi.org/10.1016/j.rce.2023.07.002"
},
{
"label": "Content Type",
"name": "content_type",
"value": "article"
},
{
"label": "Copyright",
"name": "copyright",
"value": "© 2023 Elsevier España, S.L.U. and Sociedad Española de Medicina Interna (SEMI). All rights reserved."
}
],
"author": [
{
"affiliation": [],
"family": "Galindo-Andúgar",
"given": "M.A.",
"sequence": "first"
},
{
"affiliation": [],
"family": "Arias Arias",
"given": "Á.",
"sequence": "additional"
},
{
"affiliation": [],
"family": "Alfonso García Guerra",
"given": "J.",
"sequence": "additional"
},
{
"affiliation": [],
"family": "Fernández Visier",
"given": "I.",
"sequence": "additional"
},
{
"affiliation": [],
"family": "Manuel Fernández Ibáñez",
"given": "J.",
"sequence": "additional"
},
{
"affiliation": [],
"family": "Bellido Maldonado",
"given": "A.",
"sequence": "additional"
}
],
"container-title": "Revista Clínica Española (English Edition)",
"container-title-short": "Revista Clínica Española (English Edition)",
"content-domain": {
"crossmark-restriction": true,
"domain": [
"elsevier.es",
"elsevier.com",
"sciencedirect.com"
]
},
"created": {
"date-parts": [
[
2023,
7,
21
]
],
"date-time": "2023-07-21T07:38:40Z",
"timestamp": 1689925120000
},
"deposited": {
"date-parts": [
[
2023,
7,
27
]
],
"date-time": "2023-07-27T13:54:51Z",
"timestamp": 1690466091000
},
"indexed": {
"date-parts": [
[
2023,
7,
28
]
],
"date-time": "2023-07-28T04:13:26Z",
"timestamp": 1690517606143
},
"is-referenced-by-count": 0,
"issued": {
"date-parts": [
[
2023,
7
]
]
},
"language": "en",
"license": [
{
"URL": "https://www.elsevier.com/tdm/userlicense/1.0/",
"content-version": "tdm",
"delay-in-days": 0,
"start": {
"date-parts": [
[
2023,
7,
1
]
],
"date-time": "2023-07-01T00:00:00Z",
"timestamp": 1688169600000
}
}
],
"link": [
{
"URL": "https://api.elsevier.com/content/article/PII:S2254887423000929?httpAccept=text/xml",
"content-type": "text/xml",
"content-version": "vor",
"intended-application": "text-mining"
},
{
"URL": "https://api.elsevier.com/content/article/PII:S2254887423000929?httpAccept=text/plain",
"content-type": "text/plain",
"content-version": "vor",
"intended-application": "text-mining"
}
],
"member": "78",
"original-title": [],
"prefix": "10.1016",
"published": {
"date-parts": [
[
2023,
7
]
]
},
"published-print": {
"date-parts": [
[
2023,
7
]
]
},
"publisher": "Elsevier BV",
"reference": [
{
"DOI": "10.1096/fj.202001807",
"article-title": "Rationale for the use of N-acetylcysteine in both prevention and adjuvant therapy of COVID-19",
"author": "De Flora",
"doi-asserted-by": "crossref",
"first-page": "13185",
"journal-title": "FASEB J",
"key": "10.1016/j.rceng.2023.07.006_bib0005",
"volume": "34",
"year": "2020"
},
{
"DOI": "10.1007/s10930-020-09935-8",
"article-title": "Role of oxidative stress on SARS-CoV (SARS) and SARS-CoV-2 (COVID-19) infection: a review",
"author": "Suhail",
"doi-asserted-by": "crossref",
"first-page": "644",
"journal-title": "Protein J",
"key": "10.1016/j.rceng.2023.07.006_bib0010",
"volume": "39",
"year": "2020"
},
{
"DOI": "10.1016/j.toxrep.2020.06.003",
"article-title": "Reactive oxygen species as an initiator of toxic innate immune responses in retort to SARS-CoV-2 in an ageing population, consider N-acetylcysteine as early therapeutic intervention",
"author": "Nasi",
"doi-asserted-by": "crossref",
"first-page": "768",
"journal-title": "Toxicol Rep",
"key": "10.1016/j.rceng.2023.07.006_bib0015",
"volume": "7",
"year": "2020"
},
{
"article-title": "Therapeutic potential of N-acetyl cysteine (NAC) in preventing cytokine storm in COVID-19: review of current evidence",
"author": "Mohanty",
"first-page": "2802",
"journal-title": "Eur Rev Med Pharmacol Sci",
"key": "10.1016/j.rceng.2023.07.006_bib0020",
"volume": "25",
"year": "2021"
},
{
"DOI": "10.3389/fchem.2021.685196",
"article-title": "Changes in glycolytic pathway in SARS-COV 2 infection and their importance in understanding the severity of COVID-19",
"author": "Santos",
"doi-asserted-by": "crossref",
"journal-title": "Front Chem",
"key": "10.1016/j.rceng.2023.07.006_bib0025",
"volume": "9",
"year": "2021"
},
{
"DOI": "10.1016/j.mehy.2020.109862",
"article-title": "N-Acetylcysteine: a potential therapeutic agent for SARS-CoV-2",
"author": "Poe",
"doi-asserted-by": "crossref",
"journal-title": "Med Hypotheses",
"key": "10.1016/j.rceng.2023.07.006_bib0030",
"volume": "143",
"year": "2020"
},
{
"DOI": "10.3949/ccjm.87a.ccc046",
"article-title": "What is the role of supplementation with ascorbic acid, zinc, vitamin D, or N-acetylcysteine for prevention or treatment of COVID-19?",
"author": "Bauer",
"doi-asserted-by": "crossref",
"journal-title": "Cleve Clin J Med",
"key": "10.1016/j.rceng.2023.07.006_bib0035",
"year": "2020"
},
{
"DOI": "10.3390/v13030425",
"article-title": "The combination of bromelain and acetylcysteine (BromAc) synergistically inactivates SARS-CoV-2",
"author": "Akhter",
"doi-asserted-by": "crossref",
"first-page": "425",
"journal-title": "Viruses",
"key": "10.1016/j.rceng.2023.07.006_bib0040",
"volume": "13",
"year": "2021"
},
{
"DOI": "10.3390/antiox10020272",
"article-title": "Potential role of antioxidant and anti-inflammatory therapies to prevent severe SARS-Cov-2 complications",
"author": "Fratta Pasini",
"doi-asserted-by": "crossref",
"first-page": "272",
"journal-title": "Antioxidants (Basel)",
"key": "10.1016/j.rceng.2023.07.006_bib0045",
"volume": "10",
"year": "2021"
},
{
"DOI": "10.5501/wjv.v10.i2.34",
"article-title": "Bottom-up analysis of emergent properties of N-acetylcysteine as an adjuvant therapy for COVID-19",
"author": "Dominari",
"doi-asserted-by": "crossref",
"first-page": "34",
"journal-title": "World J Virol",
"key": "10.1016/j.rceng.2023.07.006_bib0050",
"volume": "10",
"year": "2021"
},
{
"DOI": "10.2147/TCRM.S273700",
"article-title": "N-Acetylcysteine to combat COVID-19: an evidence review",
"author": "Shi",
"doi-asserted-by": "crossref",
"first-page": "1047",
"journal-title": "Ther Clin Risk Manag",
"key": "10.1016/j.rceng.2023.07.006_bib0055",
"volume": "16",
"year": "2020"
},
{
"DOI": "10.1155/2021/9949453",
"article-title": "N-Acetylcysteine: a review of clinical usefulness (an old drug with new tricks)",
"author": "Schwalfenberg",
"doi-asserted-by": "crossref",
"journal-title": "J Nutr Metab",
"key": "10.1016/j.rceng.2023.07.006_bib0060",
"volume": "2021",
"year": "2021"
},
{
"DOI": "10.1016/j.rce.2020.07.003",
"article-title": "Clinical characteristics of patients hospitalized with COVID-19 in Spain: Results from the SEMI-COVID-19 Registry",
"author": "Casas-Rojo",
"doi-asserted-by": "crossref",
"first-page": "480",
"journal-title": "Rev Clin Esp",
"key": "10.1016/j.rceng.2023.07.006_bib0065",
"volume": "220",
"year": "2020"
},
{
"DOI": "10.1183/16000617.0152-2021",
"article-title": "Asthma and COVID-19: an update",
"author": "Adir",
"doi-asserted-by": "crossref",
"journal-title": "Eur Respir Rev",
"key": "10.1016/j.rceng.2023.07.006_bib0070",
"volume": "30",
"year": "2021"
},
{
"DOI": "10.1183/13993003.03142-2020",
"article-title": "The impact of COVID-19 on patients with asthma",
"author": "Izquierdo",
"doi-asserted-by": "crossref",
"journal-title": "Eur Respir J",
"key": "10.1016/j.rceng.2023.07.006_bib0075",
"volume": "57",
"year": "2021"
},
{
"DOI": "10.1080/23744235.2021.1945675",
"article-title": "N-acetyl-cysteine reduces the risk for mechanical ventilation and mortality in patients with COVID-19 pneumonia: a two-center retrospective cohort study",
"author": "Assimakopoulos",
"doi-asserted-by": "crossref",
"first-page": "847",
"journal-title": "Infect Dis (Lond)",
"key": "10.1016/j.rceng.2023.07.006_bib0080",
"volume": "53",
"year": "2021"
},
{
"DOI": "10.1177/00368504221074574",
"article-title": "Use of N-Acetylcysteine at high doses as an oral treatment for patients hospitalized with COVID-19",
"author": "Izquierdo",
"doi-asserted-by": "crossref",
"journal-title": "Sci Prog",
"key": "10.1016/j.rceng.2023.07.006_bib0085",
"volume": "105",
"year": "2022"
},
{
"DOI": "10.1096/fj.202100560R",
"article-title": "Disruption of disulfides within RBD of SARS-CoV-2 spike protein prevents fusion and represents a target for viral entry inhibition by registered drugs",
"author": "Manček-Keber",
"doi-asserted-by": "crossref",
"journal-title": "FASEB J",
"key": "10.1016/j.rceng.2023.07.006_bib0090",
"volume": "35",
"year": "2021"
},
{
"DOI": "10.3390/cells11203313",
"article-title": "Inhibition of the cell uptake of delta and omicron SARS-CoV-2 pseudoviruses by N-acetylcysteine irrespective of the oxidoreductive environment",
"author": "La Maestra",
"doi-asserted-by": "crossref",
"first-page": "3313",
"journal-title": "Cells",
"key": "10.1016/j.rceng.2023.07.006_bib0095",
"volume": "11",
"year": "2022"
},
{
"DOI": "10.3390/ijms232314518",
"article-title": "N-acetylcysteine reduces inflammasome activation induced by SARS-CoV-2 proteins in vitro",
"author": "Milara",
"doi-asserted-by": "crossref",
"first-page": "14518",
"journal-title": "Int J Mol Sci",
"key": "10.1016/j.rceng.2023.07.006_bib0100",
"volume": "23",
"year": "2022"
},
{
"DOI": "10.1093/cid/ciaa1443",
"article-title": "Double-blind, randomized, placebo-controlled trial with N-acetylcysteine for treatment of severe acute respiratory syndrome caused by coronavirus disease 2019 (COVID-19)",
"author": "de Alencar",
"doi-asserted-by": "crossref",
"first-page": "e736",
"journal-title": "Clin Infect Dis",
"key": "10.1016/j.rceng.2023.07.006_bib0105",
"volume": "72",
"year": "2021"
},
{
"DOI": "10.1007/s43440-021-00296-2",
"article-title": "A pilot study on intravenous N-acetylcysteine treatment in patients with mild-to-moderate COVID19-associated acute respiratory distress syndrome",
"author": "Taher",
"doi-asserted-by": "crossref",
"first-page": "1650",
"journal-title": "Pharmacol Rep",
"key": "10.1016/j.rceng.2023.07.006_bib0110",
"volume": "73",
"year": "2021"
},
{
"DOI": "10.1016/j.jinf.2021.07.003",
"article-title": "N-acetylcysteine for the treatment of COVID-19 among hospitalized patients",
"author": "Avdeev",
"doi-asserted-by": "crossref",
"first-page": "94",
"journal-title": "Journal of Infection",
"key": "10.1016/j.rceng.2023.07.006_bib0115",
"volume": "84",
"year": "2022"
},
{
"DOI": "10.1016/j.jiph.2022.11.009",
"article-title": "N-acetylcysteine for prevention and treatment of COVID-19: current state of evidence and future directions",
"author": "Izquierdo-Alonso",
"doi-asserted-by": "crossref",
"first-page": "1477",
"journal-title": "J Infect Public Health",
"key": "10.1016/j.rceng.2023.07.006_bib0120",
"volume": "15",
"year": "2022"
},
{
"article-title": "N-acetylcysteine efficacy in patients hospitalized with COVID-19 pneumonia: a systematic review and meta-analysis",
"author": "Paraskevas",
"first-page": "41",
"journal-title": "Rom J Intern Med",
"key": "10.1016/j.rceng.2023.07.006_bib0125",
"volume": "61",
"year": "2023"
},
{
"DOI": "10.1097/JCMA.0000000000000869",
"article-title": "Is N-acetylcysteine effective in treating patients with coronavirus disease 2019? A meta-analysis",
"author": "Chen",
"doi-asserted-by": "crossref",
"first-page": "274",
"journal-title": "J Chin Med Assoc",
"key": "10.1016/j.rceng.2023.07.006_bib0130",
"volume": "86",
"year": "2023"
},
{
"DOI": "10.1002/jmv.28393",
"article-title": "Evaluation the efficacy and safety of N-acetylcysteine inhalation spray in controlling the symptoms of patients with COVID-19: an open-label randomized controlled clinical trial",
"author": "Panahi",
"doi-asserted-by": "crossref",
"journal-title": "J Med Virol",
"key": "10.1016/j.rceng.2023.07.006_bib0135",
"volume": "95",
"year": "2023"
},
{
"key": "10.1016/j.rceng.2023.07.006_bib0140",
"unstructured": "https://clinicaltrials.gov/ct2/results?term=acetylcysteine+%20AND%20+Covid&Search. (Accessed 19 June 2023)."
}
],
"reference-count": 28,
"references-count": 28,
"relation": {},
"resource": {
"primary": {
"URL": "https://linkinghub.elsevier.com/retrieve/pii/S2254887423000929"
}
},
"score": 1,
"short-title": [],
"source": "Crossref",
"subject": [
"General Medicine"
],
"subtitle": [],
"title": "Impact of N-Acetylcysteine in the mortality of patients hospitalized with COVID-19: a retrospective cohort study",
"type": "journal-article",
"update-policy": "http://dx.doi.org/10.1016/elsevier_cm_policy"
}
